Edgestream Partners’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
GF
Edgestream Partners's NEO Position: Q4 2024 in Review
Edgestream Partners sold out of NeoGenomics (NEO) in Q4 2024, closing a stake of 34,798 shares — an estimated $513K sold.
Edgestream Partners first reported a position in NEO in Q3 2022 and held it in 8 quarters. The position peaked at $1.89M in Q1 2024. 253 funds tracked by Wall St. Rank hold NEO as of Q4 2024.
- Edgestream Partners reported no remaining NeoGenomics position as of Q4 2024 after selling out during the quarter.
- Edgestream Partners sold 34,798 NeoGenomics shares in Q4 2024, an estimated $513K.
- Edgestream Partners first reported a position in NeoGenomics in Q3 2022 and held it in 8 quarters.
- Edgestream Partners's NeoGenomics position peaked at $1.89M in Q1 2024.
- 253 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2024.
Based on Edgestream Partners's 13F filing for Q4 2024, filed 7 Feb 2025.